Influence of gag and pol regions on replication efficiency of a multidrug-resistant HIV-1 variant:: a systematic assessment

被引：0
|
作者：
Simon, V
Padte, N
Driver, I
Wang, NC
DiMascio, M
Markowitz, M
机构：
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[2] NIAID, NIH, Bethesda, MD 20892 USA
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
77
引用
收藏
页码：U78 / U78
页数：1
相关论文
共 50 条
  • [21] Editorial comment: A plethora of options in multidrug-resistant HIV-1 infection
    Katzenstein, David A.
    AIDS READER, 2008, 18 (09): : 478 - 479
  • [22] The demise of multidrug-resistant HIV-1: the national time trend in Portugal
    Vercauteren, Jurgen
    Theys, Kristof
    Carvalho, Ana Patricia
    Valadas, Emilia
    Duque, Luis Miguel
    Teofilo, Eugenio
    Faria, Telo
    Faria, Domitilia
    Vera, Jose
    Aguas, Maria Joao
    Peres, Susana
    Mansinho, Kamal
    Vandamme, Anne-Mieke
    Camacho, Ricardo Jorge
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (04) : 911 - 914
  • [23] Multidrug-resistant, dual-tropic HIV-1 and rapid progression
    Jefferys, R
    LANCET, 2005, 365 (9475): : 1923 - 1923
  • [24] Design of HIV-1 protease inhibitors active on multidrug-resistant virus
    Surleraux, DLNG
    de Kock, HA
    Verschueren, WG
    Pille, GME
    Maes, LJR
    Peeters, A
    Vendeville, S
    De Meyer, S
    Azijn, H
    Pauwels, R
    de Bethune, MP
    King, NM
    Prabu-Jeyabalan, M
    Schiffer, CA
    Wigerinck, PBTP
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1965 - 1973
  • [25] What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?
    Grover, D.
    Copas, A.
    Green, H.
    Edwards, S. G.
    Dunn, D. T.
    Sabin, C.
    Phillips, A.
    Allen, E.
    Pillay, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 705 - 713
  • [26] Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
    Martin, Supang A.
    Cane, Patricia A.
    Pillay, Deenan
    Mbisa, Jean L.
    PATHOGENS, 2021, 10 (09):
  • [27] Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions reverse transcriptase pol gene
    Andréoletti, L
    Weiss, L
    Si-Mohamed, A
    Piketty, C
    Prazuck, T
    Calamy, G
    Malkin, JE
    Matta, M
    Mbopi-Kéou, FX
    Clavel, F
    Kazatchkine, MD
    Bélec, L
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 102 - 104
  • [28] Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus
    Lee, Natalie E. E.
    Sutherland, Rebecca K. K.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (01) : 15 - 19
  • [29] Complexity and Dynamics of HIV-1 Chemokine Receptor Usage in a Multidrug-Resistant Adolescent
    Cavarelli, Mariangela
    Mainetti, Lara
    Pignataro, Angela Rosa
    Bigoloni, Alba
    Tolazzi, Monica
    Galli, Andrea
    Nozza, Silvia
    Castagna, Antonella
    Sampaolo, Michela
    Boeri, Enzo
    Scarlatti, Gabriella
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (12) : 1243 - 1250
  • [30] Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection
    Campbell, TB
    Shulman, NS
    Johnson, SC
    Zolopa, AR
    Young, RK
    Bushman, L
    Fletcher, CV
    Lanier, ER
    Merigan, TC
    Kuritzkes, DR
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) : 236 - 242
12345